Pipeline
Our development projects
Macrobiome Therapeutics is developing novel therapeutics that will inhibit chronic debilitating diseases with limited efficacious treatment options, such as inflammatory bowel disease (IBD), type-2 diabetes (T2D) and chronic wounds.
Wound healingMBT-005 |
Molecule discovery
Assay development
Lead optimization
Pre-clinical development
Phase 1 Trials
|
||||
IBD PipelineMBT-001, MBT-002, MBT-003, MBT-004 |
Molecule discovery
Assay development
Lead optimization
Pre-clinical development
Phase 1 Trials
|
||||
T2D Pipeline8 hits |
Molecule discovery
Assay development
Lead optimization
Pre-clinical development
Phase 1 Trials
|
||||